Bessemer Group
ANIK icon

Bessemer Group’s Anika Therapeutics ANIK Stock Holding History

Bessemer Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed -$1K – 2448
2024
Q3 		$1K Buy
+50
New +$1.3K ﹤0.01% 2319
2022
Q3 		– Sell
-135
Closed -$3K – 2015
2022
Q2 		$3K Hold
135
– – ﹤0.01% 1647
2022
Q1 		$3K Buy
+135
New +$4.12K ﹤0.01% 1662
2020
Q3 		– Sell
-118
Closed -$4K – 1346
2020
Q2 		$4K Buy
+118
New +$3.89K ﹤0.01% 1576
2016
Q4 		– Sell
-412
Closed -$20K – 1932
2016
Q3 		$20K Buy
+412
New +$20.4K ﹤0.01% 1367

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $254M AUM 98.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return